August 26th 2025, 5:00pm
After an blood cancer diagnosis and stem cell transplant, I found purpose in crochet, turning fear into creativity and connection one stitch at a time.
August 26th 2025, 4:00pm
Rina-S earned breakthrough therapy designation for patients with advanced endometrial cancer whose disease has worsened after platinum-based chemotherapy.
August 26th 2025, 3:00pm
The FDA granted breakthrough device designation to Quest Diagnostics’ Haystack MRD test for patients with stage 2 colorectal cancer after surgery.
August 26th 2025, 1:00pm
Kristen Dahlgren of the Cancer Vaccine Coalition spoke with CURE about patients’ need to find reliable sources of information.
August 25th 2025, 9:00pm
What does standing up to cancer mean to me? It meant I got to choose the terms of my fight instead of relinquishing that to an uncurable disease.
August 25th 2025, 8:00pm
The FDA has granted rusfertide breakthrough therapy designation for patients with polycythemia vera, a step that could speed its path to approval.
August 25th 2025, 7:00pm
Dr. Neal Patel says biopsy results may not fully capture prostate cancer risk, stressing that PSA, stage and disease volume should also guide treatment.
August 25th 2025, 5:00pm
In patients with high-risk myelodysplastic syndromes, hypomethylating agents are underutilized, particularly among older, female and non-White patients.
August 25th 2025, 4:00pm
Creating our own metaphors to stand up to cancer can help with the healing journey; own words can give us a better sense of control.
August 25th 2025, 3:00pm
DecisionDx-SCC may help doctors more accurately guide treatment in high-risk cutaneous squamous cell carcinoma, the second most common form of skin cancer.
Why Leaving a Breast Cancer Legacy Matters to Me
How Does Colorectal Cancer Screening Prevent and Detect Cancer?
TAR-200 Eliminates Bladder Cancer in 82% of Patients
GLP-1 Therapy Linked to Improved Outcomes in Polycythemia Vera